February 4, 2025 AI Ventures Soar as Trade Tensions Heat Up – Key Weekly Highlights
January 27, 2025 China’s DeepSeek Challenges U.S. AI Giants, Shakes Tech Markets
January 23, 2025 Trump’s AI Revolution: Stargate Initiative Sparks Economic Surge
Tesla's Resilience Amid Challenges: A Strategic Buy Opportunity
Tesla: Navigating Challenges Amid Accelerating Innovation Shifts
Nvidia: Unlocking Hidden Catalysts Driving Future Value
Amazon's Q4 Outlook: Navigating Tariffs and Growth Potential
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
Esperion Therapeutics (ESPR) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: February 6, 2025 (11:28)
Sector: HealthcareThe share price of Esperion Therapeutics, Inc. (ESPR) now
Are you interested in Esperion Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Esperion Therapeutics stock price in 2025, 2026, 2027. How much will one Esperion Therapeutics share be worth in 2025 - 2027?
When should I take profit in Esperion Therapeutics stock? When should I record a loss on Esperion Therapeutics stock? What are analysts' forecasts for Esperion Therapeutics stock? What is the future of Esperion Therapeutics stock? We forecast Esperion Therapeutics stock performance using neural networks based on historical data on Esperion Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Esperion Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Esperion Therapeutics shares. This happens once a day.
Historical and forecast chart of Esperion Therapeutics stock
The chart below shows the historical price of Esperion Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Esperion Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Esperion Therapeutics is a publicly available US pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated LDL-C levels.
Esperion Therapeutics daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Feb 08 | 1.85 | 1.82 | 1.90 | 4.43 |
Feb 09 | 1.85 | 1.83 | 1.88 | 2.34 |
Feb 10 | 1.88 | 1.85 | 1.93 | 4.10 |
Feb 11 | 1.83 | 1.79 | 1.87 | 4.26 |
Feb 12 | 1.81 | 1.78 | 1.86 | 4.93 |
Feb 13 | 1.85 | 1.81 | 1.88 | 3.68 |
Feb 14 | 1.85 | 1.80 | 1.87 | 4.11 |
Feb 15 | 1.85 | 1.83 | 1.88 | 2.83 |
Feb 16 | 1.78 | 1.73 | 1.83 | 5.59 |
Feb 17 | 1.75 | 1.73 | 1.80 | 4.17 |
Feb 18 | 1.74 | 1.70 | 1.79 | 5.62 |
Feb 19 | 1.76 | 1.72 | 1.80 | 4.83 |
Feb 20 | 1.79 | 1.77 | 1.84 | 4.26 |
Feb 21 | 1.79 | 1.74 | 1.84 | 5.24 |
Feb 22 | 1.84 | 1.79 | 1.86 | 3.95 |
Feb 23 | 1.82 | 1.80 | 1.85 | 2.67 |
Feb 24 | 1.82 | 1.79 | 1.84 | 2.81 |
Feb 25 | 1.87 | 1.85 | 1.90 | 2.47 |
Feb 26 | 1.86 | 1.81 | 1.89 | 4.53 |
Feb 27 | 1.82 | 1.80 | 1.84 | 2.27 |
Feb 28 | 1.84 | 1.80 | 1.88 | 4.82 |
Mar 01 | 1.86 | 1.81 | 1.92 | 6.00 |
Mar 02 | 1.85 | 1.82 | 1.90 | 4.73 |
Mar 03 | 1.93 | 1.90 | 1.96 | 3.12 |
Mar 04 | 1.98 | 1.93 | 2.02 | 4.59 |
Mar 05 | 2.01 | 1.98 | 2.04 | 3.21 |
Mar 06 | 2.01 | 1.99 | 2.04 | 2.58 |
Mar 07 | 2.02 | 2.00 | 2.06 | 2.95 |
Mar 08 | 2.01 | 1.97 | 2.05 | 3.87 |
Mar 09 | 1.95 | 1.93 | 1.99 | 3.16 |
Esperion Therapeutics Daily Price Targets
Esperion Therapeutics Stock Forecast 02-08-2025.
Forecast target price for 02-08-2025: $1.85.
Negative dynamics for Esperion Therapeutics shares will prevail with possible volatility of 4.246%.
Pessimistic target level: 1.82
Optimistic target level: 1.90
Esperion Therapeutics Stock Forecast 02-09-2025.
Forecast target price for 02-09-2025: $1.85.
Positive dynamics for Esperion Therapeutics shares will prevail with possible volatility of 2.287%.
Pessimistic target level: 1.83
Optimistic target level: 1.88
Esperion Therapeutics Stock Forecast 02-10-2025.
Forecast target price for 02-10-2025: $1.88.
Positive dynamics for Esperion Therapeutics shares will prevail with possible volatility of 3.938%.
Pessimistic target level: 1.85
Optimistic target level: 1.93
Esperion Therapeutics Stock Forecast 02-11-2025.
Forecast target price for 02-11-2025: $1.83.
Negative dynamics for Esperion Therapeutics shares will prevail with possible volatility of 4.083%.
Pessimistic target level: 1.79
Optimistic target level: 1.87
Esperion Therapeutics Stock Forecast 02-12-2025.
Forecast target price for 02-12-2025: $1.81.
Negative dynamics for Esperion Therapeutics shares will prevail with possible volatility of 4.701%.
Pessimistic target level: 1.78
Optimistic target level: 1.86
Esperion Therapeutics Stock Forecast 02-13-2025.
Forecast target price for 02-13-2025: $1.85.
Positive dynamics for Esperion Therapeutics shares will prevail with possible volatility of 3.550%.
Pessimistic target level: 1.81
Optimistic target level: 1.88
ESPR (ESPR) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Mar. | 2.19 | 1.91 | 2.73 | 30.06 |
Apr. | 2.32 | 2.07 | 2.55 | 18.84 |
May. | 2.66 | 2.16 | 3.02 | 28.37 |
Jun. | 1.84 | 1.60 | 2.01 | 20.48 |
Jul. | 1.64 | 1.28 | 1.85 | 30.91 |
Aug. | 1.99 | 1.52 | 2.34 | 34.87 |
Sep. | 2.19 | 1.67 | 2.59 | 35.64 |
Oct. | 2.42 | 2.25 | 2.90 | 22.51 |
Nov. | 2.06 | 1.72 | 2.20 | 21.54 |
Dec. | 1.42 | 1.32 | 1.56 | 15.79 |
Esperion Therapeutics forecast for this year
Esperion Therapeutics Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $2.18881. Pessimistic: $1.91. Optimistic: $2.73
Esperion Therapeutics Stock Prediction for Apr 2025
An uptrend is forecast for this month with an optimal target price of $2.31773. Pessimistic: $2.07. Optimistic: $2.55
Esperion Therapeutics Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $2.65542. Pessimistic: $2.16. Optimistic: $3.02
Esperion Therapeutics Stock Prediction for Jun 2025
An downtrend is forecast for this month with an optimal target price of $1.84047. Pessimistic: $1.60. Optimistic: $2.01
Esperion Therapeutics Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $1.63508. Pessimistic: $1.28. Optimistic: $1.85
Esperion Therapeutics Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $1.99496. Pessimistic: $1.52. Optimistic: $2.34
Esperion Therapeutics Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $2.19286. Pessimistic: $1.67. Optimistic: $2.59
Esperion Therapeutics Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $2.42398. Pessimistic: $2.25. Optimistic: $2.90
Esperion Therapeutics Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $2.0633. Pessimistic: $1.72. Optimistic: $2.20
Esperion Therapeutics Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $1.42367. Pessimistic: $1.32. Optimistic: $1.56
Esperion Therapeutics (ESPR) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 1.32 | 1.03 | 1.51 | 31.74 |
Feb | 1.29 | 1.05 | 1.53 | 31.37 |
Mar | 1.64 | 1.49 | 1.90 | 21.41 |
Apr | 1.91 | 1.51 | 2.11 | 28.40 |
May | 2.30 | 1.95 | 2.70 | 27.81 |
Jun | 3.01 | 2.68 | 3.63 | 25.99 |
Jul | 3.10 | 2.37 | 3.50 | 32.18 |
Aug | 3.81 | 3.05 | 4.69 | 35.05 |
Sep | 4.84 | 3.85 | 5.67 | 32.05 |
Oct | 4.56 | 3.53 | 4.95 | 28.81 |
Nov | 5.12 | 3.85 | 5.90 | 34.72 |
Dec | 5.60 | 4.92 | 6.61 | 25.49 |
Esperion Therapeutics (ESPR) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 5.44 | 4.31 | 6.42 | 32.84 |
Feb | 5.88 | 4.79 | 6.89 | 30.46 |
Mar | 6.76 | 5.29 | 8.10 | 34.66 |
Apr | 7.16 | 5.89 | 7.62 | 22.70 |
May | 9.37 | 8.59 | 11.35 | 24.32 |
Jun | 9.17 | 8.32 | 11.28 | 26.22 |
Jul | 6.47 | 6.05 | 7.49 | 19.27 |
Aug | 6.21 | 5.13 | 7.46 | 31.22 |
Sep | 4.38 | 3.57 | 5.15 | 30.82 |
Oct | 3.72 | 2.83 | 4.46 | 36.64 |
Nov | 3.95 | 3.00 | 4.46 | 32.64 |
Dec | 3.88 | 3.15 | 4.33 | 27.25 |
Esperion Therapeutics information and performance
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US
Market capitalization of the Esperion Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ESPR shares in the company outstanding by the market price of one share.
EBITDA of Esperion Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Esperion Therapeutics Stock)
Should I Buy Esperion Therapeutics Shares in 2025 year?
Does Esperion Therapeutics pay dividends?
Which economic sector do Esperion Therapeutics's shares belong to?
Which other securities belong to the same sector as Esperion Therapeutics's shares?
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.